Non-fungible Tokens (NFT) in Healthcare Market Size is valued at USD 177.3 Mn in 2024 and is predicted to reach USD 934.1 Mn by the year 2034 at a 18.2% CAGR during the forecast period for 2025-2034.

Non-fungible tokens are unique and significant digital assets stored on a blockchain, offering potential to transform healthcare by enhancing data security, patient control, and transparency. In healthcare, NFTs are primarily explored for patient-centric data management (46% of applications), enabling patients to own, track, and monetize their health data, such as genomic or wearable device records, through decentralized platforms.
Additionally, NFTs can motivate patients to participate by offering an enjoyable and rewarding way to monitor and improve health in return for monetary incentives. It is therefore anticipated that this will quicken market expansion. However, the lack of regulatory frameworks may make it more difficult to develop, approve, and launch new goods, which could affect the Non-fungible Tokens (NFT) in the Healthcare market's overall growth. On the other hand, NFTs can boost patient engagement by offering an enjoyable and rewarding way to monitor and enhance health in return for monetary incentives. This will support future Non-fungible Tokens (NFT) in Healthcare market expansion.
The Non-fungible Tokens (NFT) in the Healthcare market are segmented based on blockchain used, application area, and end-user. Based on the Blockchain Used, the market is segmented into Ethereum, Polygon, HyperLedger, and Others. By Application Area, the market is segmented into Health Records Management, Supply Chain Management, Health and Wellness, Genomics Research, Clinical Trial Consent, and Others. By End-user, the market is segmented into Patients, Pharmaceutical Companies, Healthcare Professionals, Insurance Companies, Academic Institutions / Government Bodies, and Others.
The Ethereum category is expected to hold a major global market share in 2021. This is because smart contracts that don't need to be verified by a third party were first introduced by the Ethereum blockchain, which provides more security and anonymity. Additionally, the development and use of more private blockchains are anticipated to propel the growth of NFT solutions that use other blockchains in the upcoming ten years. Furthermore, the growing emphasis on patient data ownership and monetization, along with the development of digital therapies and personalized medicine, has increased demand for NFT solutions based on Ethereum.
The Non-Fungible Tokens (NFT) in the healthcare market's Insurance Companies category are expanding significantly because of the growing interest in blockchain technology usage to improve the efficiency, security, and transparency of healthcare insurance operations. In order to facilitate claims processing and lower fraud, insurance companies are investigating NFTs as a means of tokenizing patient information, medical records, and treatment histories. This will enable safe and impenetrable record-keeping. The increasing requirement for interoperability among healthcare systems and the need for more individualized and traceable insurance solutions serve as additional catalysts for this adoption.
The North American Non-fungible Tokens (NFT) in the Healthcare market are expected to register the highest market share in revenue in the near future, driven by the increasing desire of interested parties to manage the expanding volume of medical data.The region's dominance in Non-fungible Tokens (NFT) within the Healthcare sector is further augmented by its strong healthcare infrastructure and the presence of numerous prominent blockchain and IT firms. In addition, Asia Pacific is projected to grow rapidly in the global Non-fungible Tokens (NFT) in the Healthcare market, mainly ascribed to the growing R&D effort, the impending product releases, and the growing awareness and usage of NFTs in this area. Additionally, it is anticipated that the growing use of cryptocurrencies in Asia-Pacific nations will propel regional market expansion.
In Nov 2024: The Universal Health Token (UHT), supported by Animoca Brands, marked the successful selling of its inaugural NFT collection, intended to serve as a benefits pass for forthcoming project initiatives, collaborations, and product launches. The collection, entitled ‘PILLARS OF HEALTH,’ consisted of 1,500 complimentary mint NFTs, all of which were claimed through a first-come-first-served mechanism, with 918 NFTs allocated via assured locations.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD xx Mn |
| Revenue Forecast In 2034 | USD xx Mn |
| Growth Rate CAGR | CAGR of xx% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Blockchain Used, Application Area, And End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Universal Health Token, Aimedis, Epillo Health, GenoBank.io, Genomes.io, IVIRSE, Molecule, Rejuve.AI, BurstIQ, ChainCode Consulting, DeHealth, and TuumIO. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Non-fungible Tokens (NFT) in Healthcare Market By Blockchain Used

Non-fungible Tokens (NFT) in Healthcare Market By Application Area
Non-fungible Tokens (NFT) in Healthcare Market By End-user
Non-fungible Tokens (NFT) in Healthcare Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.